Policy on HepB Vaccines Used on Day 1 of Life in US Is Not Based on Evidence of Protection Against HepB Viral Infection
ACIP has no reason to expect that Dose 1 in the series is beneficial to anything other than onboarding parents to the vaccine program.
I consume massive quantities of literature each week. It is reasonable to expect that ACIP might be looking into the individual benefit:risk ratio of HepB, especially given the tip-off by an article I mention later. So I went to find the evidence of benefit. To the patient. The individual newborn patient.
In this article, I follow the conventional terminology: “Neonatal” = birth (hour 0) through 27 days 23:59 hours of life—i.e., the first 28 completed days after birth. (Within this interval, very early neonatal = 0 to <24 hours of life, early neonatal = ≥24 hours to <7 days, and late neonatal = ≥7 to <28 days. But we don’t refer to those periods here).
What exists (U.S.-only):
Clinical immunogenicity papers in U.S. neonates either (a) begin vaccination at ≥2 months or (b) start at birth but draw sera after dose #2 or after series—so they do not report protection after the birth dose alone.
• Goldfarb et al., randomized U.S. neonatal trial comparing 0–1–6 vs 0–1–2 schedules, bled at 2, 3, 6, 7 months; seroprotection is presented at 3 months (after two doses), not after the birth dose alone. PubMedU.S. product labeling (RECOMBIVAX HB®, ENGERIX‑B®) shows neonatal efficacy against perinatal transmission and immunogenicity after the full series, not after a single birth dose; labeling also formalizes the correlate anti‑HBs ≥10 mIU/mL. U.S. Food and Drug Administration
U.S. policy (ACIP 2018): infants of HBsAg‑positive mothers must receive HBIG + vaccine within 12 hours because active protection is not immediate; the report explicitly uses ≥10 mIU/mL as the protection threshold and times serologic checks after the last dose. U.S. Food and Drug Administration CDC
I could find no U.S. neonatal cohort that measured and reported anti‑HBs at ~1 month after the birth dose, before dose #2.
Immunology Says Individual Benefit of Day 1 Dose Not Likely
Newborns are capable of priming transient partially adaptive responses to protein antigens on alum, but protective titers generally require weeks and booster exposure(s); germinal center maturation and Tfh helper cells constraints slow early quantitative responses to a fraction of those vaccinated. These dynamics are well‑established in human neonatal immunology. PubMed JOURNAL LINK
In early life, the T follicular helper cell (Tfh) program is only partially engaged: transcriptomic comparisons show that neonatal Tfh are “pre‑Tfh,” with under‑expression of signature genes (e.g., BCL6, CXCR5, IL‑21, c‑MAF) and a TH2‑skew; CpG adjuvantation can push these cells toward a committed GC‑Tfh state in experimental systems. Independent human data document reduced CD40L (CD154) expression on activated neonatal CD4⁺ T cells, a bottleneck for T‑cell help to B cells, with mechanistic work localizing limits to both proximal and distal signaling. These constraints are factual and repeatedly shown in primary studies (see for example Study 1, Study 2, Study 3).
In the past, the basis of ACIP recommendation for Day 1 was shifted to justification by the efficacy of the series. There was never any direct evidence that Day 1 medical procedure performed on millions of individual infants had a proper benefit-to-the-individual: risk-to-the-individual ratio.
There still is none.
The toxicity of aluminum hydroxide is per body-weight dose dependent. Yet studies of chronic illness in infants vaccinated on Day 1 vs Day 180 also do not exist.
So if ACIP were to shift the start of HepB for infants born to HBsAg‑negative mothers to say, three months, the chance of individual benefit for the first dose should increase substantially (due to increased Tff helper cell maturation) and the risk of aluminum hydroxide dose-related toxicity would be reduced.
That makes sense to me.
Not surprisingly, MedPageToday published this article
Maybe now that I’ve explained what the science says, it will make more sense to them, too.
My understanding is people only get hep B passed from mother or needles and sex (which wouldn't apply to kids). Now we find out it really doesn't help even for kids with hep B mothers!?
WTF I'm so disgusted with pharma & vax industry.
One grandkid had eczema, the other hair loss and I'm wondering if those monsters caused harm to these perfect little humans.
Excellent dive into the literature, Dr. Jack! You went where no one else has gone, with the precision needed to help ACIP do the right thing. We must get away from forcing mothers who are exhausted from giving birth from being bullied into a medical procedure that could harm their children for life. In 2002, I gave birth to my twins. I said no to the Hep B vaccine because the logic wasn’t there. I didn’t even know what I know now. But I knew it didn’t make sense. I pushed back, but I didn’t have what it took to prevail. I was exhausted and bullied into allowing them to vaccinate my newborns with hepatitis B vaccine. I very much regret it.
The other key point here is that this bullying around the hepatitis B vaccine at birth relies on an argument that the benefit is to the newborn. That fallacious argument is used as a basis to call child protective services on parents who say no to the Hep B vaccine in the hospital.
The hepatitis B vaccine was put on the children’s schedule because authorities said they couldn’t reach the IV drug users on the streets so it was easier to vaccinate newborns to get “herd immunity.” if this is the purported reason for injecting newborns with hepatitis B, MDs are practicing public health above a patient’s health. That is a conflict of interest. A doctor‘s duty is to their patient, not to public health.
Finally, we know that this excuse about not reaching the IV drug users was just a pretense to get the hepatitis B vaccines on the children’s schedule so that the manufacturers could get liability protection.
Your research blows up their entire case for vaccinating newborns with hepatitis B. There’s no need to call child protective services because there is no individual protection from the first dose of hepatitis B vaccine. There’s no need to prioritize public health over the health of a newborn, because that violates the Hippocratic oath.
The newborn vaccination scheme is a monstrous and reckless act of child endangerment.